Cross Country Healthcare, Inc. (CCRN)
NASDAQ: CCRN · Real-Time Price · USD
12.96
+0.17 (1.33%)
Oct 24, 2025, 4:00 PM EDT - Market closed
Cross Country Healthcare Revenue
Cross Country Healthcare had revenue of $274.07M in the quarter ending June 30, 2025, a decrease of -19.34%. This brings the company's revenue in the last twelve months to $1.19B, down -24.30% year-over-year. In the year 2024, Cross Country Healthcare had annual revenue of $1.34B, down -33.46%.
Revenue (ttm)
$1.19B
Revenue Growth
-24.30%
P/S Ratio
0.35
Revenue / Employee
$124,158
Employees
9,605
Market Cap
424.60M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.34B | -675.72M | -33.46% |
| Dec 31, 2023 | 2.02B | -783.65M | -27.95% |
| Dec 31, 2022 | 2.80B | 1.13B | 67.20% |
| Dec 31, 2021 | 1.68B | 840.24M | 100.46% |
| Dec 31, 2020 | 836.42M | 14.19M | 1.73% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
CCRN News
- 2 days ago - Cross Country Marketing Team Wins Global OnCon Icon Award; Named No. 1 in the Nation - Business Wire
- 2 months ago - Cross Country Healthcare Announces Second Quarter 2025 Financial Results - Business Wire
- 4 months ago - Cross Country Healthcare: At This Price, The Pending Acquisition Is Worth Betting On (Rating Upgrade) - Seeking Alpha
- 6 months ago - Cross Country Healthcare Announces First Quarter 2025 Financial Results - Business Wire
- 6 months ago - Nursing in 2025: No Relief in Sight as Burnout, Stress & Short Staffing Persist - Business Wire
- 8 months ago - Cross Country Healthcare Announces Fourth Quarter and Full Year 2024 Financial Results - Business Wire
- 8 months ago - Cross Country Healthcare Stockholders Approve Aya Healthcare Transaction - Business Wire
- 9 months ago - CROSS COUNTRY HEALTHCARE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Cross Country Healthcare, Inc. - CCRN - Business Wire